Co-Author
This page shows the publications co-authored by Daniel Solomon and Rishi Desai.
Connection Strength
2.795
-
Use of large healthcare databases for rheumatology clinical research. Curr Opin Rheumatol. 2017 03; 29(2):138-143.
Score: 0.700
-
Association of Preoperative Opioid Use With Mortality and Short-term Safety Outcomes After Total Knee Replacement. JAMA Netw Open. 2019 07 03; 2(7):e198061.
Score: 0.206
-
Association of Geography and Access to Health Care Providers With Long-Term Prescription Opioid Use in Medicare Patients With Severe Osteoarthritis: A Cohort Study. Arthritis Rheumatol. 2019 05; 71(5):712-721.
Score: 0.202
-
Cardiovascular Risks of Probenecid Versus Allopurinol in Older Patients With Gout. J Am Coll Cardiol. 2018 03 06; 71(9):994-1004.
Score: 0.188
-
An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout. PLoS One. 2018; 13(2):e0193622.
Score: 0.187
-
Practice Pattern of Hepatitis B Testing in Rheumatoid Arthritis Patients: A Cross-National Comparison Between the US and Taiwan. Arthritis Care Res (Hoboken). 2018 01; 70(1):30-38.
Score: 0.185
-
Temporal Trends in Use of Biologic DMARDs for Rheumatoid Arthritis in the United States: A Cohort Study of Publicly and Privately Insured Patients. J Manag Care Spec Pharm. 2017 Aug; 23(8):809-814.
Score: 0.180
-
Tumor Necrosis Factor-a Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis. Epidemiology. 2016 May; 27(3):414-22.
Score: 0.165
-
Identification of smoking using Medicare data--a validation study of claims-based algorithms. Pharmacoepidemiol Drug Saf. 2016 Apr; 25(4):472-5.
Score: 0.162
-
An external validation study reporting poor correlation between the claims-based index for rheumatoid arthritis severity and the disease activity score. Arthritis Res Ther. 2015 Apr 13; 17:83.
Score: 0.154
-
Disease-modifying antirheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: a retrospective cohort study. Arthritis Care Res (Hoboken). 2015 Apr; 67(4):457-66.
Score: 0.153
-
Risk of venous thromboembolism associated with methotrexate versus hydroxychloroquine for rheumatoid arthritis: A propensity score-matched cohort study. Semin Arthritis Rheum. 2021 12; 51(6):1242-1250.
Score: 0.060
-
Development of a Medicare Claims-Based Model to Predict Persistent High-Dose Opioid Use After Total Knee Replacement. Arthritis Care Res (Hoboken). 2021 Jan 15.
Score: 0.057
-
Risk of malignancy associated with use of tocilizumab versus other biologics in patients with rheumatoid arthritis: A multi-database cohort study. Semin Arthritis Rheum. 2019 10; 49(2):222-228.
Score: 0.050
-
Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study. Ann Rheum Dis. 2019 04; 78(4):456-464.
Score: 0.050
-
Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study. Circulation. 2018 09 11; 138(11):1116-1126.
Score: 0.049
-
Patterns of Systemic Treatment for Psoriatic Arthritis in the US: 2004-2015. Arthritis Care Res (Hoboken). 2018 05; 70(5):791-796.
Score: 0.047
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.